This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Kura Oncology, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Yue Lu: Innovator in Pharmaceutical Compounds
Introduction
Yue Lu is a prominent inventor based in Ningbo, China. She has made significant contributions to the field of pharmaceuticals, particularly in the development of solid forms of macrocyclic compounds. Her work is crucial in advancing treatments for various medical conditions, including cancer.
Latest Patents
Yue Lu holds 1 patent for her invention titled "Solid forms of macrocyclic compounds, salts and formulations thereof, and methods of preparing and using the same." This patent relates to solid forms of Compound 1, which includes pharmaceutically acceptable forms, salts, and solvates. The invention also encompasses pharmaceutical compositions and methods for treating cancer that depend on a farnesylated protein.
Career Highlights
Yue Lu is currently employed at Kura Oncology, Inc., where she continues to innovate in the pharmaceutical sector. Her expertise in macrocyclic compounds has positioned her as a valuable asset in the research and development of new cancer treatments.
Collaborations
Yue collaborates with Kenneth K Liu, enhancing her research efforts and contributing to the advancement of their projects.
Conclusion
Yue Lu's work in the field of pharmaceuticals exemplifies the impact of innovative thinking on medical advancements. Her contributions are paving the way for new treatments that could significantly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile